KSC 2020 | 64th Annual Scientific Meeting of The Korean Society of Cardiology

Program at a Glance

Symposium
Intervention 1
Which Evidence-Based NOAC Should Be the Preferred Dual Anti-thrombotic Regimen in AF Patients Undergoing PCI?
Oct. 16 (Fri.) 17:20-18:50, Channel 04

Chairpersons: Kyoo Rok Han, Youngkeun Ahn
Panel: Woong Chol Kang, Sung Eun Kim, Jung-Sun Kim, Joon Hyung Doh, Young Joon Hong

17:20 - 17:35

P2Y12 Inhibitor with Rivaroxaban

[Speaker] Kyung Woo Park/Seoul National Univ.,Korea

17:35 - 17:50

P2Y12 Inhibitor with Dabigatran

[Speaker] Suk Min Seo/Catholic Univ.,Korea

17:50 - 18:05

P2Y12 Inhibitor with Apixaban

[Speaker] Hong-Seok Lim/Ajou Univ.,Korea

18:05 - 18:20

P2Y12 Inhibitor with Edoxaban

[Speaker] Jae Hyung Park/Korea Univ.,Korea

18:20 - 18:50

Discussion